1 |
MORSHED S A, DAVIES T F. Graves' disease mechanisms:the role of stimulating,blocking,and cleavage region TSH receptor antibodies[J]. Horm Metab Res, 2015, 47(10):727-734.
DOI
URL
|
2 |
SOH S B, AW T C. Laboratory testing in thyroid conditions-pitfalls and clinical utility[J]. Ann Lab Med, 2019, 39(1):3-14.
DOI
URL
|
3 |
MORSHED S A, LATIF R, DAVIES T F. Characterization of thyrotropin receptor antibody-induced signaling cascades[J]. Endocrinology, 2009, 150(1):519-529.
DOI
PMID
|
4 |
LUTTRELL B M, HALES I B. Thyroid stimulating immunoglobulin in Graves' disease[J]. Aust N Z J Med, 1981, 11(3):293-298.
|
5 |
VILLALTA D, ORUNESU E, TOZZOLI R, et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers[J]. J Clin Pathol, 2004, 57(4):378-382.
DOI
PMID
|
6 |
TOZZOLI R, D'AURIZIO F, VILLALTA D, et al. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves' disease[J]. Clin Chem Lab Med, 2017, 55(1):58-64.
DOI
URL
|
7 |
Clinical and Laboratory Standards Institute. User verification of precision and estimation of bias[S]. EP15-A3,CLSI, 2014.
|
8 |
Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures:a statistical approach[S]. EP06-A,CLSI, 2003.
|
9 |
Clinical and Laboratory Standards Institute. Method comparison and bias estimation using patient samples[S]. EP9-A2,CLSI, 2002.
|
10 |
Clinical and Laboratory Standards Institute. User protocol for evaluation of qualitative test performance[S]. EP12-A2,CLSI, 2008.
|
11 |
LANDIS J R, KOCH G G. The measurement of observer agreement for categorical data[J]. Biometrics, 1977, 33(1):159-174.
PMID
|
12 |
ROSS D S, BURCH H B, COOPER D S, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Thyroid,2016, 26(10):1343-1421.
DOI
URL
|
13 |
YAMASHITA S, AMINO N, SHONG Y K. The American thyroid association and american association of clinical endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines:viewpoints from Japan and Korea[J]. Thyroid, 2011, 21(6):577-580.
DOI
URL
|
14 |
KIM J J, JEONG S H, KIM B, et al. Analytical and clinical performance of newly developed immunoassay for detecting thyroid-stimulating immunoglobulin,the Immulite TSI assay[J]. Scand J Clin Lab Invest, 2019, 79(6):443-448.
DOI
URL
|
15 |
AUTILIO C, MORELLI R, LOCANTORE P, et al. Stimulating TSH receptor autoantibodies immunoassay:analytical evaluation and clinical performance in Graves' disease[J]. Ann Clin Biochem, 2018, 55(1):172-177.
DOI
URL
|
16 |
BLUSZCZ G A, BEDNARCZUK T, BARTOSZEWICZ Z, et al. Clinical utility of TSH receptor antibody levels in Graves' orbitopathy:a comparison of two TSH receptor antibody immunoassays[J]. Cent Eur J Immunol, 2018, 43(4):405-412.
|
17 |
ALLELEIN S, EHLERS M, GORETZKI S, et al. Clinical evaluation of the first automated assay for the detection of stimulating TSH receptor autoantibodies[J]. Horm Metab Res, 2016, 48(12):795-801.
PMID
|
18 |
CHENG X, CHAI X, MA C, et al. Clinical diagnostic performance of a fully automated TSI immunoassay vs. that of an automated antiTSHR immunoassay for Graves' disease:a Chinese multicenter study[J]. Endocrine, 2021, 71(1):139-148.
DOI
URL
|
19 |
张利霞, 汪蕾, 郭琳, 等. 促甲状腺素受体刺激性抗体检测的临床意义[J]. 标记免疫分析与临床, 2019, 26(12):1985-1987.
|
20 |
钟丽, 张静, 张双婕, 等. IMMULITE化学发光TSI检测分析性能验证及临床性能评估[J]. 标记免疫分析与临床, 2021, 28(2):339-342.
|
21 |
刘天琪, 张秀英, 纪立农. 促甲状腺激素受体抗体的检测及应用进展[J]. 国际内分泌代谢杂志, 2021, 41(1):5-9.
|